Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Operating Expenses | 0 | 464 | 379 | 790 | 262 |
| Operating Income | N/A | -464 | -379 | -790 | -262 |
| Other Income | 0 | 33 | 35 | 80 | 6 |
| Pre-tax Income | 0 | -431 | -344 | -710 | -256 |
| Net Income Continuous | N/A | -431 | -344 | -710 | -256 |
| Net Income | $N/A | $-431 | $-344 | $-710 | $-256 |
| EPS Basic Total Ops | -0.25 | -0.08 | -0.07 | -0.14 | -0.10 |
| EPS Basic Continuous Ops | N/A | -0.08 | -0.07 | -0.14 | -0.10 |
| EPS Diluted Total Ops | -0.25 | -0.08 | -0.07 | -0.14 | -0.10 |
| EPS Diluted Continuous Ops | N/A | -0.08 | -0.07 | -0.14 | -0.10 |
| EBITDA(a) | $N/A | $-464 | $-379 | $-790 | $-259 |